• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FIT
Click for more information
0.00% 0.0¢

FITGENES LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
FIT Removal from Official List04/01/16
FIT Fitgenes Limited executes Deed of Company Arrangement24/12/15
FIT Final Director's Interest Notice23/12/15
FIT Director Appointment/Resignation23/12/15
FIT Quarterly Report September 2015 - Appendix 4C23/10/15
FIT Administrator's Update 15.10.201515/10/15
FIT Appointment of an external administrator08/10/15
FIT Status Update - Payment of Annual Listing Fees22/09/15
FIT Suspension from Official Quotation - Annual Listing FeesPRICE SENSITIVE25/08/15
FIT Initial Director's Interest Notice13/08/15
FIT Quarterly Report June 2015 - Appendix 4C07/08/15
FIT New Director Appointment06/08/15
FIT Execution of Term Sheet with Elevate Australasia PL24/07/15
FIT Quarterly Report March 2015 - Appendix 4C27/04/15
FIT Quarterly Report December 2014 - Appendix 4C27/04/15
FIT Execution of Heads of Agreement with Elevate Australasia PL10/04/15
FIT Status Update - Change of Registered Address10/04/15
FIT Final Directors Interest Notice Appendix 3Z18/11/14
FIT Director Resignation and Rotation of Chairman18/11/14
FIT Status Update - Converting Note Transfer18/11/14
FIT Quarterly Report September 2014 - Appendix 4C03/11/14
FIT Status Update - Withdrawal of Prospectus Offer14/10/14
FIT Status Update - Extension of Offer Period26/09/14
FIT General Meeting Results17/09/14
FIT Status Update - Fitgenes attending HIMSS Singapore12/09/14
FIT Status Update - AusBiotech Presentation10/09/14
FIT Status Update - Fitgenes joins Global Genomics Alliance29/08/14
FIT Status Update - Canary Networks Presentation20/08/14
FIT Chairman's Letter & Notice of EGM & Proxy Form18/08/14
FIT Status Update - Investor Presentation15/08/14
FIT Status Update - Replacement Fitgenes Prospectus04/08/14
FIT Quarterly Report June 2014 - Appendix 4C31/07/14
FIT Status Update - Fitgenes Prospectus18/07/14
FIT Status Update - Yuuwa Capital mezzanine investment26/06/14
FIT Status Update - Fitgenes opens Perth clinic16/06/14
FIT Status Update - Hong Kong joint venture incorporated16/06/14
FIT Removal from Official List
04/01/16
FIT Fitgenes Limited executes Deed of Company Arrangement
24/12/15
FIT Final Director's Interest Notice
23/12/15
FIT Director Appointment/Resignation
23/12/15
FIT Quarterly Report September 2015 - Appendix 4C
23/10/15
FIT Administrator's Update 15.10.2015
15/10/15
FIT Appointment of an external administrator
08/10/15
FIT Status Update - Payment of Annual Listing Fees
22/09/15
FIT Suspension from Official Quotation - Annual Listing Fees
25/08/15PRICE SENSITIVE
FIT Initial Director's Interest Notice
13/08/15
FIT Quarterly Report June 2015 - Appendix 4C
07/08/15
FIT New Director Appointment
06/08/15
FIT Execution of Term Sheet with Elevate Australasia PL
24/07/15
FIT Quarterly Report March 2015 - Appendix 4C
27/04/15
FIT Quarterly Report December 2014 - Appendix 4C
27/04/15
FIT Execution of Heads of Agreement with Elevate Australasia PL
10/04/15
FIT Status Update - Change of Registered Address
10/04/15
FIT Final Directors Interest Notice Appendix 3Z
18/11/14
FIT Director Resignation and Rotation of Chairman
18/11/14
FIT Status Update - Converting Note Transfer
18/11/14
FIT Quarterly Report September 2014 - Appendix 4C
03/11/14
FIT Status Update - Withdrawal of Prospectus Offer
14/10/14
FIT Status Update - Extension of Offer Period
26/09/14
FIT General Meeting Results
17/09/14
FIT Status Update - Fitgenes attending HIMSS Singapore
12/09/14
FIT Status Update - AusBiotech Presentation
10/09/14
FIT Status Update - Fitgenes joins Global Genomics Alliance
29/08/14
FIT Status Update - Canary Networks Presentation
20/08/14
FIT Chairman's Letter & Notice of EGM & Proxy Form
18/08/14
FIT Status Update - Investor Presentation
15/08/14
FIT Status Update - Replacement Fitgenes Prospectus
04/08/14
FIT Quarterly Report June 2014 - Appendix 4C
31/07/14
FIT Status Update - Fitgenes Prospectus
18/07/14
FIT Status Update - Yuuwa Capital mezzanine investment
26/06/14
FIT Status Update - Fitgenes opens Perth clinic
16/06/14
FIT Status Update - Hong Kong joint venture incorporated
16/06/14
refresh Created with Sketch. REFRESH
 

Top Stories

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.